Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Common-Stock-Shares-Outstanding" stands at 2.43 Billion United States Dollars as of 09/30/2025, the highest value since 06/30/2024.
As of the end of Johnson & Johnson's third quarter, the item "Common Stock Shares Outstanding" stands at 2.43 Billion USD. This represents an increase of 0.39 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.0288 percent compared to the value the year prior.
The 1 year change in percent is 0.0288.
The 3 year change in percent is -8.74.
The 5 year change in percent is -9.02.
The 10 year change in percent is -13.49.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Common Stock Shares Outstanding | 905,699,262,464.00 |
![]() | AbbVie Inc - Common Stock Shares Outstanding | 399,570,305,024.00 |
![]() | Roche Holding AG - Common Stock Shares Outstanding | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Common Stock Shares Outstanding | 280,205,508,085.11 |
![]() | Novartis AG - Common Stock Shares Outstanding | 255,096,620,580.91 |